Gencurix Inc (229000) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.140x

Based on the latest financial reports, Gencurix Inc (229000) has a cash flow conversion efficiency ratio of -0.140x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-1.28 Billion ≈ $-870.10K USD) by net assets (₩9.20 Billion ≈ $6.23 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Check strategic asset allocation of Gencurix Inc to assess the company's strategic physical and investment asset allocation.

Gencurix Inc - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Gencurix Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. See Gencurix Inc shareholders equity for net asset value and shareholders' equity analysis.

Gencurix Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Gencurix Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
KebNi AB (publ) ST:KEBNI-B	0.158x
Lite Strategy, Inc. NASDAQ:LITS	-0.040x
Osangjaiel Co. Ltd KQ:053980	0.027x
Cyclone Metals Ltd AU:CLE	-0.088x
Veru Inc NASDAQ:VERU	-0.166x
Theradiag SA PA:ALTHE	1.404x
Phunware Inc NASDAQ:PHUN	-0.025x
Success Transformer Corporation Bhd KLSE:7207	0.015x

Annual Cash Flow Conversion Efficiency for Gencurix Inc (2016–2024)

The table below shows the annual cash flow conversion efficiency of Gencurix Inc from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see 229000 market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩14.90 Billion ≈ $10.10 Million	₩-7.17 Billion ≈ $-4.86 Million	-0.481x	+46.80%
2023-12-31	₩12.00 Billion ≈ $8.13 Million	₩-10.86 Billion ≈ $-7.36 Million	-0.905x	+43.94%
2022-12-31	₩6.48 Billion ≈ $4.39 Million	₩-10.45 Billion ≈ $-7.08 Million	-1.614x	-497.94%
2021-12-31	₩30.99 Billion ≈ $21.00 Million	₩-8.37 Billion ≈ $-5.67 Million	-0.270x	-6.05%
2020-12-31	₩53.38 Billion ≈ $36.17 Million	₩-13.59 Billion ≈ $-9.21 Million	-0.255x	+99.24%
2019-12-31	₩155.18 Million ≈ $105.16K	₩-5.22 Billion ≈ $-3.54 Million	-33.651x	-6050.17%
2018-12-31	₩9.20 Billion ≈ $6.23 Million	₩-5.03 Billion ≈ $-3.41 Million	-0.547x	+35.20%
2017-12-31	₩6.41 Billion ≈ $4.34 Million	₩-5.41 Billion ≈ $-3.67 Million	-0.844x	-15.80%
2016-12-31	₩8.20 Billion ≈ $5.56 Million	₩-5.98 Billion ≈ $-4.05 Million	-0.729x	--

About Gencurix Inc

KQ:229000 Korea Diagnostics & Research

Market Cap

$36.76 Million

₩54.24 Billion KRW

Market Cap Rank

#23130 Global

#1583 in Korea

Share Price

₩3365.00

Change (1 day)

+29.92%

52-Week Range

₩1428.00 - ₩5870.00

All Time High

₩23845.65